2024 Sickle Cell Disease Report - Insight into Expanding Treatment Landscape and Unmet Needs
October 28, 2024 05:48 ET
|
Research and Markets
Dublin, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been...
Global Sickle Cell Disease Treatment Market Report 2024: Robust Expansions Projected by 2031 with AstraZeneca., Eli Lilly and Co, Bristol-Myers Squibb Spearheading Growth
May 29, 2024 08:00 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Sickle Cell Disease Treatment Market Size Projections Exhibit a CAGR of 20%, Likely to Attain a Value of USD 12.38 Billion by 2032
February 06, 2024 12:00 ET
|
The Brainy Insights
Newark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 2 billion in 2022 global sickle cell disease treatment market will reach USD 12.38 billion in 2032. A genetic...
Sickle Cell Disease Treatment Market Trends Report 2023-2030, Featuring Profiles of Novartis, Pfizer, GlycoMimetics, Emmaus Medical, Bristol-Myers Squibb, CRISPR Therapeutics & Graphite Bio
December 22, 2023 04:13 ET
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Blood Transfusion, Bone Marrow Transplant), By End-use...
Sickle Cell Disease Treatment Market Worth $4.69 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 08, 2023 02:53 ET
|
The Insight Partners
Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sickle cell disease (SCD) is the most common inherited blood disorder that affects the red blood cells. Treatments for SCD can relieve pain and help...
Malaria and Sickle Cell Disease Treatment Market Worth $29.17 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 03, 2023 08:33 ET
|
The Insight Partners
Pune, India, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Sickle cell disease (SCD) is the most common inherited blood disorder that affects the red blood cells. Treatments for SCD can relieve pain and help...
Sickle Cell Disease Treatment Market Size to Surpass USD 9.84 Billion by 2030, exhibiting a CAGR of 20.1%
October 16, 2023 06:42 ET
|
Fortune Business Insights
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Global Sickle Cell Disease Treatment Market Size was valued at USD 2.25 billion in 2022 and is projected to USD 9.84 billion by 2030 exhibiting a CAGR...
Sickle Cell Disease Treatment Market Size to Surpass USD 8.75 Billion by 2029, exhibiting a CAGR of 21.4%
October 05, 2023 04:46 ET
|
Fortune Business Insights
Pune, India, Oct. 05, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, the global Sickle Cell Disease Treatment Market Size was valued at USD 1.73 billion in 2021 and is projected to...
Sickle Cell Disease Treatment Market Size to Surpass Around USD 8.75 Billion by 2029 | Research Report by Fortune Business Insights
January 09, 2023 05:18 ET
|
Fortune Business Insights
Pune, India, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The global sickle cell disease treatment market size was valued at USD 1.73 billion in 2021. The market is projected to grow from USD 2.25 billion in...
The Worldwide Hemoglobinopathies Industry is Expected to Reach $7 Billion by 2031
November 10, 2022 04:48 ET
|
Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Hemoglobinopathies Market By Type, By Therapy, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...